Clinical Trial
Nutrient intake and stimulant drugs in hyperactive children
- PMID: 321504
Item in Clipboard
Clinical Trial
Nutrient intake and stimulant drugs in hyperactive children
J Am Diet Assoc.
1977 Apr.
Abstract
Recent studies have demonstrated suppressed growth of height and weight in children receiving stimulant drugs for hyperactivity. For approximately twelve months, growth data and food records were collected on two subjects receiving different types and dosages of stimulant drugs. The two cases demonstrated that dextroamphetamine levels of 10 mg. or more and methylphenidate levels of 30 mg. or more decreased caloric intake significantly. This decrease may be limiting for long-term growth. Both subjects had a variety of feeding problems due to poor appetite. Careful nutritional evaluation and planning are important to insure optimal energy and nutrient intake in these children receiving stimulant drugs.
Similar articles
-
Depression of growth in hyperactive children on stimulant drugs.N Engl J Med. 1972 Aug 3;287(5):217-20. doi: 10.1056/NEJM197208032870503. N Engl J Med. 1972. PMID: 4556640 Clinical Trial. No abstract available.
-
Growth of hyperkinetic children taking methylphenidate, dextroamphetamine, or imipramine/desipramine.Pediatrics. 1976 Sep;58(3):423-31. Pediatrics. 1976. PMID: 958770
-
Factors influencing the suppressant effects of two stimulant drugs on the growth of hyperactive children.Pediatrics. 1973 Apr;51(4):660-7. Pediatrics. 1973. PMID: 4697515 No abstract available.
-
Hyperkinetic children: the use of stimulant drugs evaluated.Am J Orthopsychiatry. 1975 Jan;45(1):28-37. doi: 10.1111/j.1939-0025.1975.tb01163.x. Am J Orthopsychiatry. 1975. PMID: 163061 Review.
-
Onset and evolution of stunting in infants and children. Examples from the Human Nutrition Collaborative Research Support Program. Kenya and Egypt studies.Eur J Clin Nutr. 1994 Feb;48 Suppl 1:S90-102. Eur J Clin Nutr. 1994. PMID: 8005095 Review.